We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NMIH:NASDAQNMI Holdings Inc Analysis

Data as of 2026-04-20 - not real-time

$39.99

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

NMI Holdings (NMIH) trades at $39.99, well below its DCF fair value of $64.0 and a P/E of 8.1 versus an industry average of 17.7, indicating a substantial valuation gap. The stock sits just above the 20‑day SMA ($38.06) and below the 50‑day SMA ($38.64), with a neutral trend, while the MACD shows a bullish crossover (line 0.32 > signal 0.09) and RSI at 64.6 suggests upward momentum without being overbought. Volatility over the past 30 days is ~19.6% and beta is low at 0.49, pointing to modest market risk. Recent news highlights an upcoming Q1 earnings release on April 30 and a notable sale of $707K worth of shares by the executive chairman, providing mixed short‑term sentiment, yet the broader market sentiment is in “Extreme Greed” (FGI 87).
Overall, the company’s high gross (78%) and operating margins, solid cash flow, and a “Buy” consensus from analysts (7 votes) support a view that the stock is fundamentally strong but temporarily pressured, making it an attractive entry point for investors seeking upside potential.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram and RSI indicating momentum
  • Significant undervaluation versus DCF and industry P/E
  • Upcoming earnings release could catalyze price movement

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained high profit margins and strong operating cash flow
  • Continued upside potential given 15.7% fair‑value upside
  • Analyst consensus leaning toward a buy recommendation

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low beta and moderate volatility support stability
  • Elevated debt‑to‑equity ratio introduces leverage risk
  • Potential regulatory and policy shifts in the specialty insurance space

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin55.05%
P/E Ratio8.1
ROE16.17%
ROA9.18%
Debt/Equity16.42
P/B Ratio1.2
Op. Cash Flow$419.3M
Free Cash Flow$267.1M
Industry P/E17.7

Technical Analysis

TrendNeutral
RSI64.6
Support$36.60
Resistance$40.31
MA 20$38.06
MA 50$38.64
MA 200$38.53
MACDBullish
VolumeDecreasing
Fear & Greed Index87.02

Valuation

Fair Value$64.03
Target Price$46.29
Upside/Downside15.74%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.49
Volatility19.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.